IRIS

Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 61 a 80 di 125
Titolo Data di pubblicazione Autore(i) File
Interleukin 28B polymorphism predicts pegylated interferon plus ribavirin treatment outcome in chronic hepatitis C genotype 4 1-gen-2012 De Nicola, S; Aghemo, A; Rumi, Mg; Galmozzi, E; Valenti, L; Soffredini, R; De Francesco, R; Prati, Gm; D'Ambrosio, R; Cheroni, C; Donato, Mf; Colombo, M
Interleukin 6 is important for survival after partial hepatectomy in mice 1-gen-2003 Blindenbacher, A; Wang, X; Langer, I; Savino, R; Terracciano, L; Heim, Mh
Is there need for more than one IL28B single nucleotide polymorphism in hepatitis C clinical practice? 1-gen-2013 Galmozzi, E; De Nicola, S; Aghemo, A; Colombo, M
JNJ-4178 (AL-335, Odalasvir, and Simeprevir) for 6 or 8 Weeks in Hepatitis C Virus-Infected Patients Without Cirrhosis: OMEGA-1 1-gen-2019 Zeuzem, S; Bourgeois, S; Greenbloom, S; Buti, M; Aghemo, A; Lampertico, P; Janczewska, E; Lim, Sg; Moreno, C; Buggisch, P; Tam, E; Corbett, C; Willems, W; Vijgen, L; Fevery, B; Ouwerkerk-Mahadevan, S; Ackaert, O; Beumont, M; Kalmeijer, R; Sinha, R; Biermer, M
Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity 1-gen-2009 Zhong, B.; Strnad, P.; Selmi, C.; Invernizzi, P.; Tao, G. Z.; Caleffi, A.; Chen, M.; Bianchi, I.; Podda, M.; Pietrangelo, A.; Gershwin, M. E.; Omary, M. B.
Lack of alanine aminotransferase normalization in patients with an anti-hcv virological response during pegylated interferon and ribavirin therapy : a sub-analysis of the mist study 1-gen-2009 Aghemo, A.; Rumi, M.; Prati, G. M.; D’Ambrosio, R.; De Nicola, S.; Colombo, M.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: first report of the IAIHG retrospective registry 1-gen-2024 Slooter, C. D.; Van Den Brand, F. F.; Lleo, A.; Colapietro, F.; Lenzi, M.; Muratori, P.; Kerkar, N.; Dalekos, G. N.; Zachou, K.; Lucena, M. I.; Robles-Diaz, M.; Di Zeo-Sanchez, D. E.; Andrade, R. J.; Montano-Loza, A. J.; Lytvyak, E.; Lissenberg-Witte, B. I.; Maisonneuve, P.; Bouma, G.; Macedo, G.; Liberal, R.; De Boer, Y. S.; Dutch AIH Study Group, ; International Autoimmune Hepatitis Group, ; Dutch AIH Study Group and International Autoimmune Hepatitis Group,
Large liver cell change in hepatitis B virus-related liver cirrhosis 1-gen-2009 Kim, H.; Oh, B. K.; Roncalli, M.; Park, C.; Yoon, S. M.; Yoo, J. E.; Park, Y. N.
Letter to the Editor: Are We Confident That Primary Biliary Cholangitis Liver‐Related Mortality Is Higher in Males? 1-gen-2021 Lleo, Ana; Hirschfield, Gideon M.
Letter to the Editor: might denosumab fit in PBC treatment? 1-gen-2019 Lleo, A; Ma, X; Gershwin, Me; Invernizzi, P
Letter to the Editor: Might Denosumab Fit in Primary Biliary Cholangitis Treatment? 1-gen-2020 Lleo, Ana; Xiong, Ma; Gershwin, M. Eric; Invernizzi, Pietro
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients 1-gen-2014 Quagliata, Luca; Matter, Matthias S; Piscuoglio, Salvatore; Arabi, Leila; Ruiz, Christian; Procino, Alfredo; Kovac, Michal; Moretti, Francesca; Makowska, Zuzanna; Boldanova, Tujana; Andersen, Jesper B; Hämmerle, Monika; Tornillo, Luigi; Heim, Markus H; Diederichs, Sven; Cillo, Clemente; Terracciano, Luigi M
Low Rates of Naturally Occurring Resistant Variants to the NS5A Inhibitor Daclatasvir in HCV-1 Null Responders 1-gen-2013 Galmozzi, E; Aghemo, A; Colombo, M
Males with primary biliary cirrhosis manifest enhanced rates of Y chromosome loss in peripheral white blood cells 1-gen-2008 Pasini, S.; Miozzo, M.; Bianchi, I.; Monti, V.; Rizzotto, E. R.; Floreani, A.; Colombo, M.; Selmi, C.; Podda, M.; Gershwin, M. E.; Invernizzi, P.
Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma 1-gen-2002 Roncalli, Massimo; Bianchi, Paolo; Bruni, Barbara; Laghi, Luigi; Destro, Annarita; Di Gioia, Sonia; Gennari, Leandro; Tommasini, Maurizio; Malesci, Alberto Carlo Piero; Coggi, Guido
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 1-gen-2008 Takahara, T; Xue, F; Mazzone, M; Yata, Y; Nonome, K; Kanayama, M; Kawai, K; Pisacane, Am; Takahara, S; Li, Xk; Comoglio, Pm; Sugiyama, T; Michieli, P
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis 1-gen-2008 Takahara, T; Xue, F; Mazzone, M; Yata, Y; Nonome, K; Kanayama, M; Kawai, K; Pisacane, Am; Takahara, S; Li, Xk; Comoglio, Paolo; Sugiyama, T; Michieli, Paolo
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 1-gen-2020 Carotenuto, P; Hedayat, S; Fassan, M; Cardinale, V; Lampis, A; Guzzardo, V; Vicentini, C; Scarpa, A; Cascione, L; Costantini, D; Carpino, G; Alvaro, D; Ghidini, M; Trevisani, F; Te Poele, R; Salati, M; Ventura, S; Vlachogiannis, G; Hahne, Jc; Boulter, L; Forbes, Sj; Guest, R; Cillo, U; Said-Huntingford, I; Begum, R; Smyth, E; Michalarea, V; Cunningham, D; Rimassa, L; Santoro, A; Roncalli, M; Kirnkin, V; Clarke, P; Workman, P; Valeri, N; Braconi, C
Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies 1-gen-2000 Maggioni, M; Coggi, G; Cassani, B; Bianchi, P; Romagnoli, S; Mandelli, A; Borzio, M; Colombo, P; Roncalli, M
Molecular classification of hepatocellular carcinoma: The view from metabolic zonation 1-gen-2017 Ng, KIU YAN CHARLOTTE; Piscuoglio, Salvatore; Terracciano, Luigi M
Mostrati risultati da 61 a 80 di 125
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile